Newswise — (NEW YORK – Feb. 19 – PLEASE HONOR EMBARGO) Male infants whose mothers were exposed during pregnancy to chemicals called phthalates may have a greater risk of future infertility, according to researchers led by Shanna H. Swan, PhD, Professor of Preventive Medicine and Obstetrics, Gynecology and Reproductive Medicine at the Icahn School of Medicine at Mount Sinai. The study, titled “First Trimester Phthalate Exposure and Anogenital Distance in Newborns” by S.H. Swan and colleagues, will be published online in the peer-reviewed journal Human Reproduction [1] on February 19 at 12:05 a.m. Eastern Standard Time and is available now on an embargoed basis.
“Our findings show that even at low levels, environmental exposure to these ubiquitous chemicals can adversely affect male genital development, which in turn may impact male reproductive health later in life,” said Dr. Swan, who is also a faculty member of The Mindich Child Health and Development Institute at Mount Sinai. “Because most pregnant women are exposed to phthalates, our findings not only have a profound effect on public health, but on the public policies meant to protect women as well as the general population.”
Specifically, the study found that male children of mothers who were exposed to phthalates during the first trimester of pregnancy, particularly diethylhexyl phthalate (DEHP) had significantly shorter anogenital distance (AGD) at birth. AGD, usually 50 to 100 percent longer in males than females, is an indicator of reproductive health. Animal and human studies have recently implicated DEHP and other phthalates, a class of environmentally pervasive industrial chemicals used extensively in various consumer products, including flooring, wallpaper, lacquers and personal care products, in a spectrum of male reproductive disorders, including shortened AGD.
AGD, the distance between the anus and the genitals, is “a sensitive marker of prenatal disruption of male genital tract development,” according to study authors. Shorter AGD in males has previously been linked to infertility and low sperm count.
This is the largest study to date on the association between phthalates and AGD. According to study authors, “prior human studies, which have been limited by small sample size and imprecise timing of exposure and / or outcome, have reported conflicting results.” The Infant Development and the Environment Study (TIDES) participants for this study were recruited in prenatal clinics in San Francisco, CA; Minneapolis, MN; Rochester, NY and Seattle, WA between 2010 and 2012, and delivered 787 infants, 753 of which were included in the analysis.
Funding for TIDES was provided by the following grants from the National Institute of Environmental Health Studies, part of the National Institutes of Health: R01ES016863-04 and R01ES016863-02S4.
[1] Human Reproduction, doi:10.1093/humrep/deu363
About the Mount Sinai Health SystemThe Mount Sinai Health System is an integrated health system committed to providing distinguished care, conducting transformative research, and advancing biomedical education. Structured around seven member hospital campuses and a single medical school, the Health System has an extensive ambulatory network and a range of inpatient and outpatient services—from community‐based facilities to tertiary and quaternary care.
The System includes approximately 6,600 primary and specialty care physicians, 12‐minority‐owned free‐standing ambulatory surgery centers, over 45 ambulatory practices throughout the five boroughs of New York City, Westchester, and Long Island, as well as 31 affiliated community health centers. Physicians are affiliated with the Icahn School of Medicine at Mount Sinai, which is ranked among the top 20 medical schools both in National Institutes of Health funding and by U.S. News & World Report.
For more information, visit http://www.mountsinai.org, or find Mount Sinai on Facebook, Twitter and YouTube.
# # #